Bio
Amit Etkin, MD, PhD, is a Professor of Psychiatry and Behavioral Sciences at Stanford University and a member of the Wu Tsai Neurosciences Institute. Dr. Etkin is trained as both as a neuroscientist and psychiatrist. He received his MD/PhD at Columbia University with Nobel laureate Eric Kandel, completed his psychiatry residency and concurrent postdoc at Stanford University with Alan Schatzberg, and joined the faculty at Stanford in 2010. Dr. Etkin has received multiple awards, most notably the NIH Director’s Pioneer Award in 2017.
The overarching aim of the Etkin lab is to understand the neural basis of emotional disorders and their treatment, and to leverage this knowledge to better understand how the brain works and to develop novel treatment interventions. In support of this goal, Dr. Etkin also collaborates with neuroscientists, engineers, psychologists, physicians and others to establish a new intellectual, scientific and clinical paradigm for understanding and manipulating human brain circuits in healthy individuals and for treating psychiatric disease.
Academic Appointments
-
Professor, Psychiatry and Behavioral Sciences
-
Member, Bio-X
-
Member, Wu Tsai Neurosciences Institute
Administrative Appointments
-
Chair, Steering Committee, Major Laboratories and Clinical Translational Neurosciences Incubator, Department of Psychiatry and Behavioral Sciences, Stanford University (2018 - Present)
-
Associate Chair, Research Strategy and Oversight, Department of Psychiatry and Behavioral Sciences, Stanford University (2018 - Present)
Honors & Awards
-
Joel Elkes Research Award, American College of Neuropsychopharmacology (2018)
-
Director's Pioneer Award, NIH (2017)
-
Young Scientist Awardee, World Economic Forum (2015)
-
Chairman's Award for Advancing Science, Stanford University (2014)
-
Dana Neuroscience Scholar award, Dana Foundation (2012)
-
Fellow, Kavli-National Academy of Science "Frontiers of Science" (2011-2013)
-
Biobehavioral Research Awards for Innovative New Scientists (BRAINS) R01 Award, NIMH (2010)
-
Outstanding Resident Award, NIMH (2008)
-
PhD awarded with distinction, Columbia University (2005)
-
Phi Beta Kappa, MIT (1997)
Boards, Advisory Committees, Professional Organizations
-
Associate Editor, Neuropsychopharmacology (2012 - 2019)
-
Editorial Board, Depression and Anxiety (2010 - Present)
-
Chair, Scientific Program Committee, Society of Biological Psychiatry (2014 - Present)
-
Fellow, American College of Neuropsychopharmacology (2011 - Present)
-
Member, Society of Biological Psychiatry (2011 - Present)
-
Scientific Advisory Board, Laureate Institute for Brain Research (Tulsa, OK) (2015 - Present)
-
Scientific Advisory Board, Akili Interactive (2016 - Present)
-
Scientific Advisory Board, Mindstrong Health (2017 - Present)
Professional Education
-
Board Certification, American Board of Psychiatry and Neurology, Psychiatry (2011)
-
MD, Columbia University, Medicine (2006)
-
PhD, Columbia University, Neurobiology (2005)
-
MPhil, Columbia University, Neurobiology (2003)
-
BS, Massachusetts Institute of Technology, Biology (1997)